Target- |
MechanismGap junctions blockers |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.GB |
First Approval Date01 Jan 1959 |
100 Clinical Results associated with Oxalys Pharmaceuticals, Inc.
0 Patents (Medical) associated with Oxalys Pharmaceuticals, Inc.
100 Deals associated with Oxalys Pharmaceuticals, Inc.
100 Translational Medicine associated with Oxalys Pharmaceuticals, Inc.